“novo-nordisk” Archives

Entry Author Date Location
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
After Orexigen Gaffe, What Role for Drugs Amid Obesity Crisis? 05/26/15 National
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
Q&A: WA Gov. Inslee on Education, Life Sciences, Climate, R&D 10/24/14 Seattle
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
West Coast Biotech Roundup: Halozyme, Nektar, Allozyne, Novo & More 09/18/14 Seattle
West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More 09/04/14 San Diego
West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More 08/21/14 San Diego
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
What Can Washington Do to Revitalize Biotech? Q&A With Gov. Inslee 10/25/13 Seattle
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
VLST, After Nine Years and $50M, Sells Assets and Winds Down 08/07/13 Seattle
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Assigning Credit and Blame to Biopharma R&D Chiefs 05/29/13 Seattle
Ophthotech Nabs $175M To Fund Late-Stage Trial For Eye Drug 05/29/13 New York
Flexion Therapeutics Secures $20 Million to Fight Osteoarthritis 12/04/12 Boston
VLST Cuts Scientific Group As Focus Shifts to Clinical Trials 09/27/12 Seattle
Novo Nordisk Weaves Itself Into Seattle Biotech, With Diabetes R&D 07/06/12 Seattle
VLST Raises $5M To Carry on With Autoimmune R&D 06/14/12 Seattle
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug 01/27/12 National
Novo Nordisk Adds Diabetes Research to Seattle Immunology Team 01/23/12 Seattle
AlloCure Stem Cell Trial Provides Glimpse of Promising Treatment for Kidney Damage 11/18/11 Boston
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News 10/06/11 Seattle
Light Sciences Oncology Stumbles in Clinical Trial, Layoffs Loom 10/04/11 Seattle
Page 1 of 3 next page »